The National Institutes of Health recently announced $79 million in funding that will go to 15 Institutional Clinical and Translational Science Awards (CTSA). The CTSA program is led by the National Center for Advancing Translational Sciences (NCATS), an NIH center established to help accelerate the process between developing new treatments and cures and delivering them to patients. One goal of the CTSA program is to enhance the efficiency, quality, and safety of translational research. These tasks are not easily achieved, and require plenty of resources and funding. The funds pledged by the NIH will aid several research institutions in discovering and improving treatments and cures for many diseases.
Fifteen institutions received 5 year awards, including $20.4 million to the University of Utah’s Center for Clinical and Translational Science. One way the center will use these funds is to search for a cure for infants diagnosed with spinal muscular atrophy, a rare and potentially fatal disease.
Read more about the Clinical and Translational Science Awards here
